Literature DB >> 16356843

Studies on calcium dependence reveal multiple modes of action for triptolide.

Stephanie J Leuenroth1, Craig M Crews.   

Abstract

Triptolide, a diterpene triepoxide isolated from the traditional Chinese medicinal vine Trypterygium wilfordii hook f., has been shown to induce rapid apoptosis in a myriad of cancer cell lines and inhibit NFkappaB transactivation. To understand further the general cellular mechanisms for this therapeutically relevant natural product, binding and biological activities were assessed. Studies showed that triptolide binding was saturable, reversible, and primarily localized to cell membranes. Depletion of calcium enhanced overall binding while differentially modulating biological function. Furthermore, triptolide's structural moieties demonstrated variability in the regulation of cell death versus inhibition of NFkappaB transactivation. These results implicate triptolide in the manipulation of at least two distinct cellular pathways with differing requirements for calcium and effective triptolide concentration in order to elicit each particular biological function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356843      PMCID: PMC2486259          DOI: 10.1016/j.chembiol.2005.09.009

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  31 in total

1.  Immunosuppressive effect of triptolide in vitro.

Authors:  H Lu; M Hachida; S Enosawa; X K Li; S Suzuki; H Koyanagi
Journal:  Transplant Proc       Date:  1999-08       Impact factor: 1.066

2.  Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation.

Authors:  D Qiu; G Zhao; Y Aoki; L Shi; A Uyei; S Nazarian; J C Ng; P N Kao
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

3.  PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells.

Authors:  K Y Lee; W Chang; D Qiu; P N Kao; G D Rosen
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

4.  A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.

Authors:  X Tao; J J Cush; M Garret; P E Lipsky
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

5.  Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.

Authors:  X H Jiang; B C Wong; M C Lin; G H Zhu; H F Kung; S H Jiang; D Yang; S K Lam
Journal:  Oncogene       Date:  2001-11-29       Impact factor: 9.867

6.  Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway.

Authors:  W T Chang; J J Kang; K Y Lee; K Wei; E Anderson; S Gotmare; J A Ross; G D Rosen
Journal:  J Biol Chem       Date:  2000-10-26       Impact factor: 5.157

7.  Triptolide: a potential male contraceptive.

Authors:  Y Lue; A P Sinha Hikim; C Wang; A Leung; S Baravarian; V Reutrakul; R Sangsawan; S Chaichana; R S Swerdloff
Journal:  J Androl       Date:  1998 Jul-Aug

8.  Analysis of the stability and degradation products of triptolide.

Authors:  Y P Mao; X L Tao; P E Lipsky
Journal:  J Pharm Pharmacol       Date:  2000-01       Impact factor: 3.765

9.  Epidermal growth factor-mediated activation of the ETS domain transcription factor Elk-1 requires nuclear calcium.

Authors:  Thomas Pusl; Julie J Wu; Tracy L Zimmerman; Lei Zhang; Barbara E Ehrlich; Martin W Berchtold; Joannes B Hoek; Saul J Karpen; Michael H Nathanson; Anton M Bennett
Journal:  J Biol Chem       Date:  2002-04-23       Impact factor: 5.157

10.  Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.

Authors:  Taija M Kiviharju; Philip S Lecane; Robert G Sellers; Donna M Peehl
Journal:  Clin Cancer Res       Date:  2002-08       Impact factor: 12.531

View more
  14 in total

1.  Molecular understanding and modern application of traditional medicines: triumphs and trials.

Authors:  Timothy W Corson; Craig M Crews
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

Review 2.  Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.

Authors:  Huanjie Yang; Q Ping Dou
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

3.  Triptolide directly inhibits dCTP pyrophosphatase.

Authors:  Timothy W Corson; Hüseyin Cavga; Nicholas Aberle; Craig M Crews
Journal:  Chembiochem       Date:  2011-06-10       Impact factor: 3.164

Review 4.  Targeting tumor proteasome with traditional Chinese medicine.

Authors:  Huanjie Yang; Jinbao Liu; Q Ping Dou
Journal:  Curr Drug Discov Technol       Date:  2010-03

5.  Triptolide induces anti-inflammatory cellular responses.

Authors:  Ranyia Matta; Xianxi Wang; Hui Ge; William Ray; Leif D Nelin; Yusen Liu
Journal:  Am J Transl Res       Date:  2009-03-05       Impact factor: 4.060

6.  Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.

Authors:  Sara M Johnson; Xiaofu Wang; B Mark Evers
Journal:  J Surg Res       Date:  2009-08-05       Impact factor: 2.192

7.  Triptolide-induced transcriptional arrest is associated with changes in nuclear substructure.

Authors:  Stephanie J Leuenroth; Craig M Crews
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease.

Authors:  Stephanie J Leuenroth; Dayne Okuhara; Joseph D Shotwell; Glen S Markowitz; Zhiheng Yu; Stefan Somlo; Craig M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

Review 9.  Therapeutic advances in ADPKD: the future awaits.

Authors:  Ivana Capuano; Pasquale Buonanno; Eleonora Riccio; Maria Amicone; Antonio Pisani
Journal:  J Nephrol       Date:  2021-05-19       Impact factor: 3.902

Review 10.  Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment.

Authors:  Rhubaniya Mahendran; Soo Kun Lim; Kien Chai Ong; Kek Heng Chua; Hwa Chia Chai
Journal:  Clin Exp Nephrol       Date:  2021-07-12       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.